Zdrowie i gospodarka · 22/11/2021

FDA Issues Final Order for Premarket Approval of Blood Lancets

The FDA is requiring manufacturers to submit a premarket approval application or product development protocol completion notice for blood lancets that were previously classified as Class I for single-use, multiple-patient use devices, now classified as Class III for multiple patient use.